Skip to Content


In the US, Ruconest (conestat alfa systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Hereditary Angioedema.

US matches:

UK matches:

Ingredient matches for Ruconest

C1 Esterase Inhibitor (Human)

C1 Esterase Inhibitor, human Conestat alfa (a derivative of C1 Esterase Inhibitor, human) is reported as an ingredient of Ruconest in the following countries:

  • Austria
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom

← International Drug Name Search

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.